178 related articles for article (PubMed ID: 24150821)
1. [Off-label use and G-BA. Legal framework for off-label use].
Brucklacher U; Brockmeyer NH; Riedel C
Hautarzt; 2013 Oct; 64(10):736-42. PubMed ID: 24150821
[TBL] [Abstract][Full Text] [Related]
2. [Appropriate off-label prescription in practice].
Augustin M
Hautarzt; 2013 Oct; 64(10):728-35. PubMed ID: 24150820
[TBL] [Abstract][Full Text] [Related]
3. [Off-label use in dermatological practice. The conflict between professional duty and legal requirements].
Brunne V; Mertins G; Reimann G; Brockmeyer NH
Hautarzt; 2004 Aug; 55(8):727-34. PubMed ID: 15241515
[TBL] [Abstract][Full Text] [Related]
4. ["With all suitable means". Off-label-use and public statutory employers' liability insurance].
Skudlik C; Lindemann B; Woltjen M; Brandenburg S; John SM
Hautarzt; 2013 Oct; 64(10):743-7. PubMed ID: 24150822
[TBL] [Abstract][Full Text] [Related]
5. Off-label use in dermatology in Germany: what has changed since 2004.
Brockmeyer NH; Brucklacher U; Potthoff A; Reich-Schupke S
J Dtsch Dermatol Ges; 2009 Nov; 7(11):938-45. PubMed ID: 19386019
[TBL] [Abstract][Full Text] [Related]
6. Off-label prescriptions and decisions on reimbursement requests in Germany - a retrospective analysis.
Seidenschnur KEK; Dressler C; Weller K; Nast A; Werner RN
J Dtsch Dermatol Ges; 2017 Nov; 15(11):1103-1109. PubMed ID: 29064628
[TBL] [Abstract][Full Text] [Related]
7. The Law and Practice of Off-Label Prescribing and Physician Promotion.
Syed SA; Dixson BA; Constantino E; Regan J
J Am Acad Psychiatry Law; 2021 Mar; 49(1):53-59. PubMed ID: 33234538
[TBL] [Abstract][Full Text] [Related]
8. Lack of a US Food and Drug Administration indication should not limit access to appropriate treatment.
Albrecht J; Adamson AS; Barbieri JS; Bennett DD; Kiracofe EA; Kourosh AS; Leslie KS; Merola JF; Nguyen J; Siegfried E; Strickland N; Olbricht S; Asgari MM;
J Am Acad Dermatol; 2019 Feb; 80(2):577-578. PubMed ID: 30244066
[No Abstract] [Full Text] [Related]
9. [Prescribing fictitiously approved drugs: regress threatens!].
Walbert H
MMW Fortschr Med; 2012 Apr; 154(6):10. PubMed ID: 22642016
[No Abstract] [Full Text] [Related]
10. Japanese regulatory system for approval of off-label drug use: evaluation of safety and effectiveness in literature-based applications.
Shimazawa R; Ikeda M
Clin Ther; 2012 Oct; 34(10):2104-16. PubMed ID: 23036337
[TBL] [Abstract][Full Text] [Related]
11. [Off-label use in psychopharmacotherapy. Letter to Federal Minister Ulla Schmidt, Pulheim, 22 January 2003].
Fritze J
Nervenarzt; 2003 Apr; 74(4):389; discussion 390. PubMed ID: 12800838
[No Abstract] [Full Text] [Related]
12. [Off-label therapy from the perspective of the medical insurance service].
Grell L; Rieger M
Z Rheumatol; 2012 Feb; 71(2):101-4, 106-7. PubMed ID: 22370800
[TBL] [Abstract][Full Text] [Related]
13. Off-label dermatologic therapies. Usage, risks, and mechanisms.
Li VW; Jaffe MP; Li WW; Haynes HA
Arch Dermatol; 1998 Nov; 134(11):1449-54. PubMed ID: 9828883
[TBL] [Abstract][Full Text] [Related]
14. [Off-label use of drugs--the legal framework].
Koyuncu A
Dtsch Med Wochenschr; 2012 Jul; 137(30):1519-23. PubMed ID: 22869512
[No Abstract] [Full Text] [Related]
15. Knowledge and perception of off-label drug use amongst prescribing physicians in a tertiary care hospital.
Kannan S; Bahl A; Khosla PP
Int J Risk Saf Med; 2015; 27(4):219-23. PubMed ID: 26756895
[TBL] [Abstract][Full Text] [Related]
16. [Off-label use in oncology: an inexhaustible topic?!].
Weissbach L; Riese J
Urologe A; 2006 Nov; 45(11):1410, 1412-4. PubMed ID: 17043888
[TBL] [Abstract][Full Text] [Related]
17. Off-label use of medical products.
National Association Of EMS Physicians
Prehosp Emerg Care; 2011; 15(3):419. PubMed ID: 21612389
[TBL] [Abstract][Full Text] [Related]
18. On-label and off-label prescribing patterns of erythropoiesis-stimulating agents in inpatient hospital settings in the US during the period of major regulatory changes.
Seetasith A; Holdford D; Shah A; Patterson J
Res Social Adm Pharm; 2017; 13(4):778-788. PubMed ID: 27595426
[TBL] [Abstract][Full Text] [Related]
19. Off-label uses of biologic agents in dermatology: a 2006 update.
Kerns MJ; Graves JE; Smith DI; Heffernan MP
Semin Cutan Med Surg; 2006 Dec; 25(4):226-40. PubMed ID: 17174843
[TBL] [Abstract][Full Text] [Related]
20. [Off-label-use in dermatology].
Sterry W
J Dtsch Dermatol Ges; 2009 Nov; 7(11):931-2. PubMed ID: 19909390
[No Abstract] [Full Text] [Related]
[Next] [New Search]
